ஆஸ்திரேலிய கணையம் புற்றுநோய் அடித்தளம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆஸ்திரேலிய கணையம் புற்றுநோய் அடித்தளம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆஸ்திரேலிய கணையம் புற்றுநோய் அடித்தளம் Today - Breaking & Trending Today

Scientists show how to attack the 'fortress' surrounding pancreatic cancer tumours – India Education | Latest Education News India | Global Educational News


Share
UNSW medical researchers have found a way to starve pancreatic cancer cells and ‘disable’ the cells that block treatment from working effectively. Their findings in mice and human lab models – which have been 10 years in the making and are about to be put to the test in a human clinical trial – are published today in 
Cancer Research, a journal of the American Association for Cancer Research.
“Pancreatic cancer has seen minimal improvement in survival for the last four decades – and without immediate action, it is predicted to be the world’s second biggest cancer killer by 2025,” says senior author Associate Professor Phoebe Phillips from UNSW Medicine & Health. ....

New South Wales , United States , Phoebe Phillips , David Goldstein , Joshua Mccarroll , Cyrille Boyer , George Sharbeen , Australian Pancreatic Cancer Foundation , University Of Queensland Professor Thomas Davis , Cancer Institute , Cancer Research , Translational Program Grant , American Association For Cancer Research , Children Cancer Institute , Medicine Health , American Association , Associate Professor Phoebe Phillips , Queensland Professor Thomas Davis , Associate Professor Joshua Mccarroll , Professor David Goldstein , புதியது தெற்கு வேல்ஸ் , ஒன்றுபட்டது மாநிலங்களில் , ஃபோப் பிலிப்ஸ் , டேவிட் கோல்ட்ஸ்டைன் , சிரில் பையன் , ஆஸ்திரேலிய கணையம் புற்றுநோய் அடித்தளம் ,

Scientists show how to attack the 'fortress' surrounding pancreatic cancer tumors


 E-Mail
Credit: UNSW Sydney
UNSW medical researchers have found a way to starve pancreatic cancer cells and disable the cells that block treatment from working effectively. Their findings in mice and human lab models - which have been 10 years in the making and are about to be put to the test in a human clinical trial - are published today in
Cancer Research, a journal of the American Association for Cancer Research.
Pancreatic cancer has seen minimal improvement in survival for the last four decades - and without immediate action, it is predicted to be the world s second biggest cancer killer by 2025, says senior author Associate Professor Phoebe Phillips from UNSW Medicine & Health. ....

United States , Phoebe Phillips , David Goldstein , Joshua Mccarroll , Cyrille Boyer , George Sharbeen , Australian Pancreatic Cancer Foundation , University Of Queensland Professor Thomas Davis , Cancer Institute , Cancer Research , Translational Program Grant , American Association For Cancer Research , Children Cancer Institute , Medicine Health , American Association , Associate Professor Phoebe Phillips , Queensland Professor Thomas Davis , Associate Professor Joshua Mccarroll , Professor David Goldstein , ஒன்றுபட்டது மாநிலங்களில் , ஃபோப் பிலிப்ஸ் , டேவிட் கோல்ட்ஸ்டைன் , சிரில் பையன் , ஆஸ்திரேலிய கணையம் புற்றுநோய் அடித்தளம் , புற்றுநோய் நிறுவனம் , புற்றுநோய் ஆராய்ச்சி ,

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW


Share
A national clinical trial program will test promising new targeted therapies for pancreatic cancer, one of the deadliest forms of cancers of which more than 3000 cases are diagnosed annually in Australia.
The clinical trial program (MoST–P), led by researchers and clinicians at UNSW and the Garvan Institute, will provide patients with access to either targeted therapies matched to the genomic signature of their individual tumour, or targeted to the tumour environment.
UNSW Dean of Medicine & Health, Professor Vlado Perkovic said the grant could lead to better outcomes for pancreatic cancer patients and more personalised approaches to treatment.
“Our researchers constantly challenge existing knowledge on cancer and are at the forefront of advances in cancer research. The trial announced today is an exciting development in pancreatic cancer research and offers hope for the future for people affected by this terrible disease,” Prof. Perkovic said. ....

New South Wales , Marina Pajic , David Goldstein , Ursula Sansom Daly , Christina Signorelli , Vlado Perkovic , Catherine Caldon , Paul Timpson , Lorraine Chantrill , Anthony Gill , Robert Weatheritt , Phoebe Phillips , Emmy Fleuren , David Thomas , Ksenia Skvortsova , Katrin Sjoquist , Australian Pancreatic Cancer Foundation , Garvan Institute , Cancer Institute , Translational Cancer Research Network , University Of Sydney , Translational Program Grant , Dean Of Medicine Health , Career Development Fellowship , Garvan Institute Of Medical Research , Australian Pancreatic Cancer Genome Initiative ,